TG Therapeutics's total assets for Q1 2025 were $656.69M, an increase of 13.67% from the previous quarter. TGTX total liabilities were $419.40M for the fiscal quarter, a 18.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.